fampridine

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

CognitionGastrointestinal Stromal TumorCerebellar Ataxia

88 competitors in Cognition

#DrugCompanyPhaseTrials

1

Revia

Teva

Approved

12

Lexapro

AbbVie

Approved

13

Coumadin

AAbbott

Approved

14

Neurontin

VViatris Specialty LLC

Approved

15

Namenda

AbbVie

Phase 3

36

Fintepla

UCB

Approved

17

Epidiolex

Jazz Pharmaceuticals

Phase 2

28

Nuplazid

AACADIA Pharmaceuticals Inc.

Phase 2

19

Remimazolam Tosilate

FFujian Shengdi Pharmaceutical Co., Ltd.

Phase 3

110

fampridine

Biogen

Phase 3

1Show 44 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Multiple Sclerosis5 trials

Open-Label Study to Assess the Effect of Long-Term Prolonged-Release Fampridine (BIIB041) on Quality of Life as Reported by Participants With Multiple Sclerosis

Completed·Biogen·Phase 4·NCT01480076·901 enrolled

Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking Technique

Completed·UUniversity of Southern Denmark·N/A·NCT03847545·48 enrolled

Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis

Unknown status·UUniversity of Zurich·Phase 2·NCT01576354·70 enrolled

Show 2 more trials

Efficacy and Safety Study of Prolonged-Release Fampridine in Participants With Multiple Sclerosis

Completed·Biogen·Phase 3·NCT02219932·646 enrolled

Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.

Completed·—·Phase 4·NCT02849782·89 enrolled

Effectiveness1 trial

A Study of the Effectiveness of Fampridine in Improving Upper Limb Function in MS

Completed·UUniversity College Dublin·Phase 4·NCT02208050·64 enrolled

Observational Study1 trial

An Observational Study to Collect Information on Safety and to Document the Drug Utilization of Fampyra (BIIB041) When Used In Routine Medical Practice

Completed·Biogen··NCT01480063·4,734 enrolled

Cerebellar Ataxia1 trial

A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene

Recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT07185347·70 enrolled

Prolonged1 trial

Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients

Completed·CClinique Neuro-Outaouais·Phase 4·NCT02146534·44 enrolled

3 more indications

Pregnancy1 trial

Fampridine Pregnancy Exposure Registry

Terminated·Biogen··NCT01532154·1 enrolled

Gastrointestinal Stromal Tumor1 trial

Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor

Recruiting·UUniversity of California, San Diego·Phase 1·NCT07171203·18 enrolled

Cognition1 trial

Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis

Completed·GGenesis Pharma CNS & Specialty··NCT03164018·111 enrolled

Details

Drug Info

Related News